Loading clinical trials...
Loading clinical trials...
Nowadays approximately 80% of children and adolescents with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL) can be cured and become long-term survivors. Avascular osteonecroses (ON...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu
NCT05795647 · Medication-related Osteonecrosis of the Jaw (MRONJ)
NCT02981628 · Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, and more
NCT04043494 · Lymphoblastic Lymphoma, Childhood
NCT07545616 · Osteonecrosis of the Femoral Head
NCT04972942 · T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma
Department of Paediatric and Adolescend Medicine, University Aachen
Aachen
Department of Pediatrics, Haematology and Oncology, University Bonn
Bonn
Department for Children and Adolescent Helth Chemnitz gGmbH
Chemnitz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions